Doximity to Acquire Amion, Leader in Physician Scheduling

Go back to Doximity to Acquire Amion, Leader in Physician Scheduling

Doximity Inc (DOCS) PT Lowered to $70 at Needham & Company

February 9, 2022 6:58 AM EST

Needham & Company analyst Scott Berg lowered the price target on Doximity Inc (NYSE: DOCS) to $70.00 (from $90.00) while maintaining a Buy rating following results.

The analyst commented, "Doximity reported its biggest revenue outperformance to date in 3QF22 as its customers increased spend that converted... More